BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
poly medicure limited stock

POLY MEDICURE LIMITED Share Price

2841.1 -65.09 (-2.23%)
Dec 13 2024 03:30 PM Healthcare NSE: POLYMED

POLY MEDICURE LIMITED Share Price Update

As of the latest trading session, POLY MEDICURE LIMITED share price is currently at 2841.1, which is down by -65.09 from its previous closing. Today, the stock has fluctuated between 2820.00 and 2901.20. Over the past year, POLY MEDICURE LIMITED has achieved a return of 77.19 %. In the last month alone, the return has been 7.00 %. Read More...

POLY MEDICURE LIMITED Performance

Day Range

Low2820.00 High2901.20
2841.10

52 Week Range

Low 1361.00 High 3357.80
2841.10

POLY MEDICURE LIMITED Share Price

25718

531768

POLYMED

img img img img
No Data Available

Open Price

2901.20

Prev. Close

2906.20

Volume (Shares)

81242.00

Total traded value

2308.16

Upper Circuit

3487.40

Lower Circuit

2325.00

Note: The current prices & values are delayed, Login to your account for live updates.

POLY MEDICURE LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 27266.44
PE Ratio (TTM) 98.90
Book Value / Share 254.10
Beta 0.60
ROE 18.70%
EPS (TTM) 28.77
Dividend Yield 0.10%
Net Profit Qtr (Cr) 87.22

POLY MEDICURE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 402.47
Operating Expense 312.78
Net Profit 87.22
Net Profit Margin (%) 21.67
Earnings Per Share (EPS) 8.99
EBITDA 140.17
Effective Tax Rate (%) 25.40
Particulars JUN 2024 (Values in Cr)
Revenue 367.42
Operating Expense 288.18
Net Profit 72.30
Net Profit Margin (%) 19.67
Earnings Per Share (EPS) 7.53
EBITDA 118.04
Effective Tax Rate (%) 24.73
Particulars MAR 2024 (Values in Cr)
Revenue 360.93
Operating Expense 282.61
Net Profit 70.53
Net Profit Margin (%) 19.54
Earnings Per Share (EPS) 7.35
EBITDA 113.06
Effective Tax Rate (%) 24.94
Particulars DEC 2023 (Values in Cr)
Revenue 320.86
Operating Expense 255.34
Net Profit 61.46
Net Profit Margin (%) 19.15
Earnings Per Share (EPS) 6.41
EBITDA 100.97
Effective Tax Rate (%) 25.13
Particulars SEP 2023 (Values in Cr)
Revenue 319.90
Operating Expense 254.72
Net Profit 59.21
Net Profit Margin (%) 18.50
Earnings Per Share (EPS) 6.17
EBITDA 95.38
Effective Tax Rate (%) 24.06
Particulars MAR 2024 (Values in Cr)
Revenue 1307.25
Operating Expense 1030.53
Net Profit 251.72
Net Profit Margin (%) 19.25
Earnings Per Share (EPS) 26.24
EBITDA 407.68
Effective Tax Rate (%) 24.83
Particulars MAR 2023 (Values in Cr)
Revenue 1068.05
Operating Expense 867.50
Net Profit 179.04
Net Profit Margin (%) 16.76
Earnings Per Share (EPS) 18.67
EBITDA 300.77
Effective Tax Rate (%) 24.39
Particulars MAR 2022 (Values in Cr)
Revenue 879.36
Operating Expense 723.37
Net Profit 146.02
Net Profit Margin (%) 16.60
Earnings Per Share (EPS) 15.23
EBITDA 250.87
Effective Tax Rate (%) 25.01
Particulars MAR 2021 (Values in Cr)
Revenue 747.38
Operating Expense 593.29
Net Profit 129.51
Net Profit Margin (%) 17.32
Earnings Per Share (EPS) 14.54
EBITDA 227.60
Effective Tax Rate (%) 25.30
Particulars MAR 2020 (Values in Cr)
Revenue 646.16
Operating Expense 542.96
Net Profit 92.38
Net Profit Margin (%) 14.29
Earnings Per Share (EPS) 10.47
EBITDA 178.72
Effective Tax Rate (%) 24.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 153.18
ROE % 19.05
ROCE % 23.44
Total Debt to Total Equity 0.12
EBITDA Margin 30.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 129.41
ROE % 15.39
ROCE % 18.95
Total Debt to Total Equity 0.12
EBITDA Margin 27.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 113.40
ROE % 14.27
ROCE % 17.26
Total Debt to Total Equity 0.13
EBITDA Margin 27.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.71
ROE % 19.40
ROCE % 21.67
Total Debt to Total Equity 0.25
EBITDA Margin 30.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 49.27
ROE % 23.49
ROCE % 24.38
Total Debt to Total Equity 0.45
EBITDA Margin 27.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 151.95
ROE % 18.70
ROCE % 23.12
Total Debt to Total Equity 0.11
EBITDA Margin 31.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.63
ROE % 15.49
ROCE % 19.21
Total Debt to Total Equity 0.11
EBITDA Margin 28.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 112.30
ROE % 14.38
ROCE % 17.54
Total Debt to Total Equity 0.12
EBITDA Margin 28.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.50
ROE % 18.72
ROCE % 21.37
Total Debt to Total Equity 0.23
EBITDA Margin 30.73
Particulars MAR 2020 (Values in Cr)
Book Value / Share 48.65
ROE % 22.84
ROCE % 24.24
Total Debt to Total Equity 0.43
EBITDA Margin 27.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 146.85
Total Assets 1858.67
Total Liabilities 1858.67
Total Equity 1470.05
Share Outstanding 95971417
Price to Book Ratio 10.46
Return on Assets (%) 13.89
Return on Capital (%) 15.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 177.63
Total Assets 1577.20
Total Liabilities 1577.20
Total Equity 1241.62
Share Outstanding 95944342
Price to Book Ratio 7.41
Return on Assets (%) 11.36
Return on Capital (%) 12.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.43
Total Assets 1376.83
Total Liabilities 1376.83
Total Equity 1087.48
Share Outstanding 95900342
Price to Book Ratio 8.45
Return on Assets (%) 10.64
Return on Capital (%) 12.08
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.56
Total Assets 1223.73
Total Liabilities 1223.73
Total Equity 965.57
Share Outstanding 95880567
Price to Book Ratio 8.22
Return on Assets (%) 11.10
Return on Capital (%) 12.36
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 25.35
Total Assets 767.32
Total Liabilities 767.32
Total Equity 434.82
Share Outstanding 88246980
Price to Book Ratio 4.84
Return on Assets (%) 12.49
Return on Capital (%) 15.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 136.94
Total Assets 1821.34
Total Liabilities 1821.34
Total Equity 1458.24
Share Outstanding 95971417
Price to Book Ratio 10.46
Return on Assets (%) 13.82
Return on Capital (%) 15.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 170.95
Total Assets 1537.76
Total Liabilities 1537.76
Total Equity 1234.12
Share Outstanding 95944342
Price to Book Ratio 7.41
Return on Assets (%) 11.64
Return on Capital (%) 13.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.31
Total Assets 1333.96
Total Liabilities 1333.96
Total Equity 1076.97
Share Outstanding 95900342
Price to Book Ratio 8.45
Return on Assets (%) 10.94
Return on Capital (%) 12.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.40
Total Assets 1187.41
Total Liabilities 1187.41
Total Equity 954.00
Share Outstanding 95880567
Price to Book Ratio 8.22
Return on Assets (%) 10.90
Return on Capital (%) 12.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 22.39
Total Assets 739.95
Total Liabilities 739.95
Total Equity 429.28
Share Outstanding 88246980
Price to Book Ratio 4.84
Return on Assets (%) 12.48
Return on Capital (%) 15.81
Particulars MAR 2024 (Values in Cr)
Net Income 344.26
Cash from Operations 340.38
Cash from Investing -240.93
Cash from Financing -20.15
Net change in Cash 4.99
Free Cash Flow 617.39
Particulars MAR 2023 (Values in Cr)
Net Income 237.49
Cash from Operations 248.91
Cash from Investing -179.24
Cash from Financing -12.50
Net change in Cash -0.69
Free Cash Flow 488.19
Particulars MAR 2022 (Values in Cr)
Net Income 195.24
Cash from Operations 170.92
Cash from Investing -85.33
Cash from Financing -35.33
Net change in Cash 2.80
Free Cash Flow 326.50
Particulars MAR 2021 (Values in Cr)
Net Income 180.05
Cash from Operations 163.35
Cash from Investing -435.58
Cash from Financing 316.94
Net change in Cash 0.09
Free Cash Flow 258.48
Particulars MAR 2020 (Values in Cr)
Net Income 125.72
Cash from Operations 164.23
Cash from Investing -107.25
Cash from Financing -20.50
Net change in Cash 0.53
Free Cash Flow 270.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.05 0.00 3.89 116.29 44.00 / 107.94
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2883.60
  • 26 Days 2820.30
  • 10 Days 2872.30
  • 50 Days 2695.20
  • 12 Days 2852.20
  • 100 Days 2516.80
  • 20 Days 2813.00
  • 200 Days 1689.70
2923.75
PIVOT
First Resistance 2962.50
Second Resistance 3018.80
Third Resistance 3057.55
First Support 2867.45
Second Support 2828.70
Third Support 2772.40
RSI 52.98
MACD 31.88
Commodity Channel Index (CCI) 43.28
ADX 13.84
Williams % R -51.53

Over 1 Month

down

7.00

Over 3 Months

down

11.89

Over 6 Months

down

52.70

Over 1 Year

down

77.19

Over 3 Years

down

43.37

Over 5 Years

down

68.59

POLY MEDICURE LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

POLY MEDICURE LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
13.24
Promoter Holdings
62.55
FII
11.87
DII
12.32
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ezekiel Global Business Solutions Llp Shareholding of Promoter and Promoter Group 1.236132E7 12.2
Rishi Baid Shareholding of Promoter and Promoter Group 9766356.0 9.64
Zetta Matrix Consulting Llp Shareholding of Promoter and Promoter Group 8322160.0 8.22
Himanshu Baid Shareholding of Promoter and Promoter Group 7907624.0 7.81
Himanshu Baid (huf) Shareholding of Promoter and Promoter Group 3839200.0 3.79
Quant Mutual Fund - Quant Large Cap Fund Public Shareholding 3553954.0 3.51
Vcb Trading Llp Shareholding of Promoter and Promoter Group 3541144.0 3.5
Jai Polypan Pvt. Ltd. Shareholding of Promoter and Promoter Group 3352000.0 3.31
Smt. Mukulika Baid Shareholding of Promoter and Promoter Group 3062400.0 3.02
Rishi Baid (huf) Shareholding of Promoter and Promoter Group 2780000.0 2.74
Jugal Kishore Baid Shareholding of Promoter and Promoter Group 2279376.0 2.25
Nirmala Vinodkumar Daga Public Shareholding 1864593.0 1.84
Smallcap World Fund, Inc Public Shareholding 1813423.0 1.79
Uti - Healthcare Fund Public Shareholding 1800676.0 1.78
Max Life Insurance Company Limited A/c R Eversionary Bonus Participating - Equity Public Shareholding 1730542.0 1.71
Vishal Baid Shareholding of Promoter and Promoter Group 1681360.0 1.66
Varun Daga Public Shareholding 1558224.0 1.54
Shreans Daga Public Shareholding 1464845.0 1.45
Shaily Baid Shareholding of Promoter and Promoter Group 1188000.0 1.17
Lighthouse India Fund Iv Aif Public Shareholding 1175426.0 1.16
Shireen Baid Shareholding of Promoter and Promoter Group 1121600.0 1.11
Neha Baid Shareholding of Promoter and Promoter Group 1024000.0 1.01
Dhruv Baid Shareholding of Promoter and Promoter Group 360000.0 0.36
Arham Baid Shareholding of Promoter and Promoter Group 280000.0 0.28
Aaryaman Baid Shareholding of Promoter and Promoter Group 280000.0 0.28
Madhu Kothari Shareholding of Promoter and Promoter Group 151200.0 0.15
Vinay Kothari Shareholding of Promoter and Promoter Group 56000.0 0.06
Polycure Martech Limited Shareholding of Promoter and Promoter Group 10000.0 0.01
Bhupendra Raj Mehta Shareholding of Promoter and Promoter Group 1600.0 0.0

POLY MEDICURE LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-21 3.0 Final 2023-09-22 Equity shares 2022-09-16 2.5 Final 2022-09-19 Equity shares 2021-09-16 2.5 Final 2021-09-17 Equity shares 2020-02-27 2.0 Interim 2020-02-29 Equity shares 2019-09-13 2.0 Final 2019-09-17 Equity shares 2018-09-18 2.0 Final 2018-09-20 Equity shares 2017-09-20 0.5 Final 2017-09-22 Equity shares 2017-02-15 1.0 Interim 2 2017-02-16 Equity shares 2016-11-11 1.0 Interim 2016-11-15 Equity shares 2016-09-19 0.5 Final 2016-09-21 Equity shares 2016-03-17 2.5 Interim 2016-03-18 Equity shares 2015-09-18 2.5 Final 2015-09-22 Equity shares 2014-09-15 4.0 Final 2014-09-17 Equity shares 2013-09-19 2.0 Final 2013-09-23 Equity shares 2012-09-13 3.0 Final 2012-09-17 Equity shares 2011-08-25 3.0 Final 2011-08-27 Equity shares 2010-08-24 2.5 Final 2010-08-26 Equity shares 2009-08-21 2.5 Final 2009-08-25 Equity shares 2007-08-23 2.5 Final 2007-08-27 Equity shares 2005-09-06 0.0 Final 2005-09-09 Equity shares
Ex-Date Ex-Bonus Ratio
2017-03-28 2017-03-24 1:1 2013-07-10 2013-07-09 1:1 2010-03-29 2010-03-26 1:1
Ex-Date Old FV NEW FV Record Date
2015-02-02 10.0 5.0 2015-02-03

Learn More About Stocks

About POLY MEDICURE LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by POLY MEDICURE LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Poly Medicure Ltd?

Answer Field

The share price of Poly Medicure Ltd for NSE is ₹ 2841.1 and for BSE is ₹ 2845.45.

What is the Market Cap of Poly Medicure Ltd?

Answer Field

The market cap of Poly Medicure Ltd for NSE is ₹ 2,72,66.44 Cr. and for BSE is ₹ 2,73,08.19 Cr. as of now.

What is the 52 Week High and Low of Poly Medicure Ltd?

Answer Field

The 52 Week High and Low of Poly Medicure Ltd for NSE is ₹ 3357.80 and ₹ 1361.00 and for BSE is ₹ 3350.00 and ₹ 1360.95.

How to Buy Poly Medicure Ltd share?

Answer Field

You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Poly Medicure Ltd?

Answer Field

The 1 year returns on the stock has been 77.19%.

What is the Current Share Price of Poly Medicure Ltd?

Answer Field

Poly Medicure Ltd share price is for NSE ₹ 2841.1 & for BSE ₹ 2845.45 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Poly Medicure Ltd Share?

Answer Field

The market cap of Poly Medicure Ltd for NSE ₹ 2,72,66.44 & for BSE ₹ 2,73,08.19 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Poly Medicure Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Poly Medicure Ltd share is 98.90.

What is the PB ratio of Poly Medicure Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Poly Medicure Ltd share is 254.10.

How to Buy Poly Medicure Ltd Share?

Answer Field

You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Poly Medicure Ltd Share on Bajaj Broking App?

Answer Field

To buy Poly Medicure Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Poly Medicure Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader